Fujifilm, GE Near Escape From Tumor Monitoring Patent Suit
A California federal judge on Thursday tentatively ruled that Fujifilm Corp. and GE Healthcare Inc. aren't infringing AntiCancer Inc.'s patents covering methods of using fluorescent proteins to monitor tumor cell growth...To view the full article, register now.
Already a subscriber? Click here to view full article